Acura Pharmaceuticals (OTCMKTS:ACUR) Shares Pass Above 200-Day Moving Average – Should You Sell?

Acura Pharmaceuticals, Inc. (OTCMKTS:ACURGet Free Report)’s share price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.00 and traded as high as $0.0008. Acura Pharmaceuticals shares last traded at $0.0008, with a volume of 1,055 shares.

Acura Pharmaceuticals Stock Performance

About Acura Pharmaceuticals

(Get Free Report)

Acura Pharmaceuticals, Inc, an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products.

See Also

Receive News & Ratings for Acura Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acura Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.